SG11201701717UA - Antiviral agents and uses thereof - Google Patents
Antiviral agents and uses thereofInfo
- Publication number
- SG11201701717UA SG11201701717UA SG11201701717UA SG11201701717UA SG11201701717UA SG 11201701717U A SG11201701717U A SG 11201701717UA SG 11201701717U A SG11201701717U A SG 11201701717UA SG 11201701717U A SG11201701717U A SG 11201701717UA SG 11201701717U A SG11201701717U A SG 11201701717UA
- Authority
- SG
- Singapore
- Prior art keywords
- antiviral agents
- antiviral
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2013420A NL2013420B1 (en) | 2014-09-05 | 2014-09-05 | Antiviral agents and uses thereof. |
| PCT/AU2015/050526 WO2016033660A1 (fr) | 2014-09-05 | 2015-09-07 | Agents antiviraux et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201701717UA true SG11201701717UA (en) | 2017-04-27 |
Family
ID=52001031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201701717UA SG11201701717UA (en) | 2014-09-05 | 2015-09-07 | Antiviral agents and uses thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10028938B2 (fr) |
| EP (1) | EP3189050B1 (fr) |
| JP (2) | JP2017525746A (fr) |
| KR (1) | KR102604939B1 (fr) |
| CN (1) | CN107108584B (fr) |
| AU (1) | AU2015311626B2 (fr) |
| BR (1) | BR112017004253B1 (fr) |
| CA (1) | CA2959548C (fr) |
| DK (1) | DK3189050T3 (fr) |
| ES (1) | ES2788475T3 (fr) |
| HU (1) | HUE049991T2 (fr) |
| MX (1) | MX2017002768A (fr) |
| NL (1) | NL2013420B1 (fr) |
| RU (1) | RU2730453C2 (fr) |
| SG (1) | SG11201701717UA (fr) |
| WO (1) | WO2016033660A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018273411B2 (en) | 2017-05-25 | 2022-12-01 | The Governors Of The University Of Alberta | Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase |
| WO2021016670A1 (fr) * | 2019-07-30 | 2021-02-04 | Griffith University | Agents antiviraux et leurs utilisations |
| US20240109886A1 (en) * | 2021-01-29 | 2024-04-04 | Griffith University | Antiviral agents and uses thereof |
| WO2024026536A1 (fr) * | 2022-08-03 | 2024-02-08 | Griffith University | Composés antiviraux et leurs utilisations |
| IT202200019842A1 (it) * | 2022-09-27 | 2024-03-27 | Policlinico San Donato S P A | Agenti antivirali per l’uso contro i virus della famiglia dei paramyxoviridae |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282950B6 (sk) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| AU7990000A (en) | 1999-10-19 | 2001-04-30 | Abbott Laboratories | Neuraminidase inhibitors |
| US7045535B2 (en) * | 2001-03-08 | 2006-05-16 | Biocryst Pharmaceuticals, Inc. | Compounds useful for inhibiting paramyxovirus neuraminidase |
| CN101787008A (zh) | 2009-01-23 | 2010-07-28 | 中国科学院上海药物研究所 | N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途 |
| CA2767453C (fr) * | 2009-07-15 | 2018-10-09 | The University Of British Columbia | Composes inhibiteurs de neuraminidase, compositions et methodes d'utilisation associees comme antiviraux |
-
2014
- 2014-09-05 NL NL2013420A patent/NL2013420B1/en not_active IP Right Cessation
-
2015
- 2015-09-07 AU AU2015311626A patent/AU2015311626B2/en active Active
- 2015-09-07 US US15/508,055 patent/US10028938B2/en active Active
- 2015-09-07 EP EP15837720.0A patent/EP3189050B1/fr active Active
- 2015-09-07 DK DK15837720.0T patent/DK3189050T3/da active
- 2015-09-07 MX MX2017002768A patent/MX2017002768A/es active IP Right Grant
- 2015-09-07 WO PCT/AU2015/050526 patent/WO2016033660A1/fr active Application Filing
- 2015-09-07 CA CA2959548A patent/CA2959548C/fr active Active
- 2015-09-07 RU RU2017110512A patent/RU2730453C2/ru active
- 2015-09-07 JP JP2017512801A patent/JP2017525746A/ja active Pending
- 2015-09-07 ES ES15837720T patent/ES2788475T3/es active Active
- 2015-09-07 HU HUE15837720A patent/HUE049991T2/hu unknown
- 2015-09-07 BR BR112017004253-3A patent/BR112017004253B1/pt active IP Right Grant
- 2015-09-07 CN CN201580060465.9A patent/CN107108584B/zh active Active
- 2015-09-07 SG SG11201701717UA patent/SG11201701717UA/en unknown
- 2015-09-07 KR KR1020177009217A patent/KR102604939B1/ko active IP Right Grant
-
2020
- 2020-09-18 JP JP2020157085A patent/JP7206241B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015311626B2 (en) | 2020-03-12 |
| RU2017110512A (ru) | 2018-10-05 |
| JP2021001204A (ja) | 2021-01-07 |
| CA2959548C (fr) | 2023-10-17 |
| US10028938B2 (en) | 2018-07-24 |
| WO2016033660A1 (fr) | 2016-03-10 |
| EP3189050A1 (fr) | 2017-07-12 |
| CN107108584A (zh) | 2017-08-29 |
| US20170290809A1 (en) | 2017-10-12 |
| BR112017004253A2 (pt) | 2017-12-12 |
| CA2959548A1 (fr) | 2016-03-10 |
| JP2017525746A (ja) | 2017-09-07 |
| CN107108584B (zh) | 2021-01-22 |
| KR102604939B1 (ko) | 2023-11-21 |
| BR112017004253B1 (pt) | 2023-01-31 |
| NL2013420B1 (en) | 2016-09-27 |
| EP3189050B1 (fr) | 2020-02-05 |
| DK3189050T3 (da) | 2020-04-27 |
| AU2015311626A1 (en) | 2017-03-23 |
| KR20170068464A (ko) | 2017-06-19 |
| JP7206241B2 (ja) | 2023-01-17 |
| RU2017110512A3 (fr) | 2019-02-19 |
| ES2788475T3 (es) | 2020-10-21 |
| MX2017002768A (es) | 2017-10-31 |
| EP3189050A4 (fr) | 2018-02-28 |
| HUE049991T2 (hu) | 2020-11-30 |
| RU2730453C2 (ru) | 2020-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243741A1 (zh) | 腫瘤壞死因子受體超家族(tnfrsf)結合劑 | |
| IL255577B (en) | Binding materials - tigit and their uses | |
| HK1231471A1 (zh) | -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途 | |
| IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| PL3152226T3 (pl) | Modyfikowane cyklopentapeptydy i ich zastosowania | |
| IL264813B (en) | 2-oxo-imidazopyridines and their use | |
| GB201401617D0 (en) | Novel combination and use | |
| GB2546834B (en) | Jet-effect use | |
| HK1243950A1 (zh) | 新型組合物和用途 | |
| HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
| SG11201701717UA (en) | Antiviral agents and uses thereof | |
| IL254241A0 (en) | Etv2 and its uses | |
| GB201418809D0 (en) | Therapeutic agents and uses thereof | |
| GB201621447D0 (en) | Use | |
| GB2545167B (en) | Cloches and use thereof | |
| GB201620350D0 (en) | Use | |
| GB201616240D0 (en) | Use | |
| GB201616203D0 (en) | Use | |
| GB201614181D0 (en) | Use | |
| GB201609921D0 (en) | Use | |
| PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
| GB201512216D0 (en) | Agents uses and methods | |
| GB201500278D0 (en) | Novel combination and use |